Xiangyu Medical

Xiangyu Medical has grown into one of China’s largest rehabilitation medical device manufacturers since its establishment in 2002. Listed on the Shanghai Stock Exchange’s STAR Market in March 2021 under the ticker 688626.SH, the company provides integrated rehabilitation solutions spanning 10 major categories, 55 product series, and nearly 1,000 individual product types.

Company Overview

Headquartered in Anyang, Henan Province, Xiangyu Medical operates as a national high-tech enterprise focused on research, manufacturing, and sales of rehabilitation equipment. The company serves general hospitals, rehabilitation centers, elderly care institutions, and disabled persons’ federations across China, with exports reaching more than 30 countries including markets in Southeast Asia, the Middle East, and Europe.

The company maintains research centers in Zhengzhou, Tianjin, Nanjing, Chengdu, Shenzhen, Shanghai, Hangzhou, and Xi’an, employing over 720 R&D personnel representing approximately 31% of its total workforce. This investment in innovation has resulted in more than 1,900 patents, including 190 invention patents, and 387 medical device registration certificates as of late 2025.

Core Products

Rehabilitation Training Equipment

Xiangyu Medical’s rehabilitation training portfolio includes intelligent lower limb feedback training systems, upper limb rehabilitation trainers, hand function training platforms, and balance assessment systems. These products have been included in China’s Rehabilitation Assistive Device Catalog and are widely deployed across Chinese hospitals.

Exoskeleton Robot Systems

The company’s portable exoskeleton walking robot, weighing 3.2 kg, entered small-batch production in June 2025 with medical device registration expected by year-end. This wearable device uses 12 micro servo motors and pressure sensors for coordinated operation, enabling paralyzed patients to achieve standing and walking functions. Clinical trials at The First Affiliated Hospital of Zhengzhou University demonstrated that patients using the device achieved independent walking capability within 3 months on average, reducing traditional rehabilitation periods by 50%.

Brain-Computer Interface Products

Through its Sun-BCI Lab established in 2017, Xiangyu Medical has developed non-invasive brain-computer interface technology covering the complete cycle of “acquisition-decoding-execution-feedback.” The company has obtained NMPA registration for EEG machines and portable EEG devices, with additional BCI products expected to receive Class II medical device certificates in the second half of 2025. In August 2025, the company launched 13 BCI devices across five product series including PT (physical therapy), OT (occupational therapy), and ST (speech therapy) rehabilitation solutions.

Physiotherapy Robot Systems

The company’s TCM moxibustion treatment robot and infrared moxibustion robot have received NMPA registration certificates, representing the application of robotic technology in traditional Chinese medicine rehabilitation.

Technology & Innovation

Xiangyu Medical’s R&D investment reached CNY 91.1 million in the first half of 2025, representing 25.4% of operating revenue with year-over-year growth of 38.8%. The company operates two specialized laboratories:

The Rehabilitation Robot Laboratory focuses on intelligent motion control, multimodal human-machine interaction, VR/MR technology, flexible wearable design, and brain-computer interface fusion rehabilitation robot control. This facility has participated in 7 national and provincial research projects and holds over 30 authorized patents.

Sun-BCI Lab concentrates on five research directions: EEG acquisition devices (Sun Link), brain-controlled products (Sun Brain), lifestyle products (Sun Live), proprietary algorithms (Sun Dip), and brain biomedical applications (Sun BME). The laboratory has undertaken 2 national key R&D programs.

The company was designated as a “National Enterprise Technology Center” by the National Development and Reform Commission in February 2022 and recognized as a “National Industrial Design Center” by the Ministry of Industry and Information Technology in 2023.

Market Presence

Xiangyu Medical’s products serve medical institutions across all 31 provincial-level administrative regions in China, with an annual production capacity of 200,000 units. The company has obtained CE certification for select products and continues pursuing FDA registration for international market expansion. Products have received medical device registration in Thailand, Vietnam, Uzbekistan, Indonesia, and Malaysia.

The company participates in international medical device exhibitions including events in Germany and Dubai, building brand recognition in global rehabilitation markets.

Key Milestones

• 2002: Company founded in Anyang, Henan Province
• 2017: Established Sun-BCI Lab for brain-computer interface research
• 2021: Listed on Shanghai STAR Market (688626.SH)
• 2022: Designated as National Enterprise Technology Center; recognized as national specialized and innovative “Little Giant” enterprise
• 2023: Recognized as National Industrial Design Center
• 2024: Ranked #2 in China Medical Device R&D Capability Rankings; accumulated over 377 medical device registration certificates
• 2025: Launched 13 BCI devices; portable exoskeleton robot enters small-batch production; partnered with Nankai University on national key R&D program for brain function remodeling robot systems

Frequently Asked Questions

What products does Xiangyu Medical offer?

Xiangyu Medical offers nearly 1,000 rehabilitation products across 10 major categories including rehabilitation training equipment, physiotherapy devices, rehabilitation nursing equipment, assistive devices, assessment systems, TCM treatment devices, health care products, medical aesthetics equipment, rehabilitation furniture, and home rehabilitation products.

Is Xiangyu Medical publicly traded?

Yes, Xiangyu Medical is listed on the Shanghai Stock Exchange’s Science and Technology Innovation Board (STAR Market) under stock code 688626.SH since March 2021.

Does Xiangyu Medical have brain-computer interface products?

Yes, the company has established Sun-BCI Lab focusing on non-invasive brain-computer interface technology for rehabilitation applications. The company has launched EEG machines, portable EEG devices, and 13 BCI-integrated rehabilitation devices across PT, OT, and ST therapy categories. Additional BCI products are expected to receive medical device registration in 2025.